St. Jude Research

Author Profile

Anna Jones, PhD

Anna Jones, PhD

Anna Jones, PhD, is an instructor in the Psychology Department at St. Jude Children’s Research Hospital.
View full bio.

Stories by Anna Jones

Assessing global pediatric cancer: Finding out what we don’t know and reaching more children
Assessing global pediatric cancer: Finding out what we don’t know and reaching more children
Outreach

Assessing global pediatric cancer: Finding out what we don’t know and reaching more children

 Nickhill Bhakta, MD, MPH

To improve the survival rate of global pediatric cancer, we must first find out how to reach many children who aren't a part of a national or regional registry.

Learn the basics of CAR T-cell immunotherapy and how it is being used in the SJCAR19 clinical trial for acute lymphoblastic leukemia
Learn the basics of CAR T-cell immunotherapy and how it is being used in the SJCAR19 clinical trial for acute lymphoblastic leukemia
Research

Learn the basics of CAR T-cell therapy and how it is being used in the SJCAR19 clinical trial at St. Jude

 Aimee Talleur, MD

Learn the basics of CAR T-cell immunotherapy and how it is being used in the SJCAR19 clinical trial for acute lymphoblastic leukemia.

Managing pain without enabling opioid addiction
Managing pain without enabling opioid addiction
Clinical

Managing pain without enabling opioid addiction

 Doralina Anghelescu, MD

How do physicians manage their patients’ pain in the context of the current opioid crises? Read how this physician helped a patient.

A moving target: Taking aim at the shift and drift of influenza viruses
A moving target: Taking aim at the shift and drift of influenza viruses
Research

A moving target: Taking aim at the shift and drift of influenza viruses

 Daniel Darnell

How close are we to a flu pandemic? Read how it could happen and what researchers are doing to prevent it.

Blazing through new territory to fight a devastating neurodegenerative disease
Blazing through new territory to fight a devastating neurodegenerative disease
Research

Blazing through new territory to fight a devastating neurodegenerative disease

 St. Jude Communications Department

Read how researchers have found a path to control coenzyme A and possibly prevent a devastating neurodegenerative disease.

Why I strive to be like my mentor
Why I strive to be like my mentor
Outreach

Why I strive to be like my mentor

 Dillon Robinson

Read how mentoring transformed a small-town college student into an epidemiologist.

Postdoc survival guide: On the road to discovery, you’re allowed to stumble at first
Postdoc survival guide: On the road to discovery, you’re allowed to stumble at first
Investigator Insights

Postdoc survival guide: On the road to big discovery, you’re allowed to stumble on your first steps

 Anthony Zamora, PhD

New lab, new investigators, new personalities, new team – learn how to make it in your first year as a postdoc.

Does obesity give influenza more time to spread and impair flu vaccines?
Does obesity give influenza more time to spread and impair flu vaccines?
Research

Can obesity give influenza more time to spread and make vaccines less effective?

 Stacey Schultz-Cherry, PhD

St. Jude researchers, led by Dr. Stacey Schultz-Cherry, are asking questions about potential association between flu severity and the obesity epidemic.

Gut microbiome predicts infection risk in leukemia patients
Gut microbiome predicts infection risk in leukemia patients
Research

Gut microbiome sequencing opens new possibilities for predicting infection in leukemia patients

 St. Jude Communications Department

Researchers identify intestinal microbiota that may predict infection risk during chemotherapy in pediatric ALL patients. Learn about the gut microbiome.

New drug for a rare disorder: How will Gamifant’s approval affect HLH treatment?
New drug for a rare disorder: How will Gamifant’s approval affect HLH treatment?
Research

New drug for a rare disorder: How will Gamifant’s approval affect HLH treatment?

 Melissa Hines, MD

HLH, a rare disorder of the immune system, is caused by a buildup of proteins responding to infection. Read about a new treatment that limits that buildup.